Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hugh Cleland Insider Profile
4 Followers
Hugh Cleland, Director at VentriPoint Diagnostics, holds 104.80K shares in Perimeter Medical Imaging AI (Ticker: TSE:PINK), holds 111.11K shares in CHAR Technologies (Ticker: TSE:YES), holds 7.75M shares in VentriPoint Diagnostics (Ticker: TSE:VPT). Most recently, Hugh Cleland Bought ― shares of Perimeter Medical Imaging AI on Nov 22, 2023 for an estimated value of 29.67K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-20.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hugh Cleland holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 23, 2020 - Oct 23, 2021
Return:+16.40%
The most profitable trade made by Hugh Cleland
Hugh Cleland's Trading History
VentriPoint Diagnostics
Jun 21, 2012
Director
Informative Buy
61.28K
C$1.12M
CHAR Technologies
Mar 22, 2022
Director
Informative Buy
50.00K
C$21.11K
Perimeter Medical Imaging AI
Nov 22, 2023
Director
Informative Buy
29.67K
C$44.02K
List of latest transactions for each holding click on a transaction to see Hugh Cleland's performance on stock
You May Also Like
Hugh Cleland insider profile FAQ
What is the percentage of profitable transactions made by Hugh Cleland?
The percentage of profitable transactions made by Hugh Cleland is 40%.
What is the average return per transaction made by Hugh Cleland?
The average return per transaction made by Hugh Cleland is -20.20%.
What stocks does Hugh Cleland hold?
Hugh Cleland holds: TSE:VPT, TSE:YES, TSE:PINK stocks.
What was Hugh Cleland’s latest transaction?
Hugh Cleland latest transaction was an Informative Buy of C$29.67K.
What was Hugh Cleland's most profitable transaction?
Hugh Cleland’s most profitable transaction was an Informative Buy of TSE:PINK stock on October 23, 2020. The return on the trade was 16.40%.
What is Hugh Cleland's role in VentriPoint Diagnostics?
Hugh Cleland's role in VentriPoint Diagnostics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.